Skip to content

Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs

Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs (ALLMED)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06112470
Acronym
ALLMED
Enrollment
20
Registered
2023-11-01
Start date
2023-02-28
Completion date
2024-03-31
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy Penicillin

Brief summary

This study focuses on the experience of the military patient reporting a suspected drug allergy, with its own specificities. Suspicions of drug allergies during a mission expose the doctor to difficulties. This study will improve understanding of the allergy patient's point of view. The end result could be a set of ideas for measures to raise awareness among these patients, and motivate them to undergo an allergological assessment.

Interventions

OTHERInterview

Semi-structured interview on experiences, perceptions, beliefs and knowledge of drug allergy and barriers to allergological testing, with a view to content analysis.

Sponsors

Direction Centrale du Service de Santé des Armées
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Military personnel (active or reservist) * Reporting a drug allergy during a periodic medical check-up or during a consultation in a medical unit * Not opposed to participating in the study.

Exclusion criteria

* Candidate on admission visit * Opposition to study * Minor (under 18 years of age) * Pregnant, parturient or breast-feeding woman * Person deprived of liberty by a judicial or administrative decision, person under psychiatric care * Non-French nationals * Person of full age subject to a legal protection measure * Person unable to express non-opposition

Design outcomes

Primary

MeasureTime frameDescription
Patients' experiences of drug allergiesThrough study completion (12 months)describe patients' experiences, perceptions, beliefs and knowledge of drug allergies in general practice in the army

Secondary

MeasureTime frameDescription
Patients' obstaclesThrough study completion (12 months)describe the obstacles to allergological assessment

Countries

France

Contacts

Primary ContactBLANCHET
marie-laure.blanchet@intradef.gouv.fr01.39.67.60.54

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026